Author: shanicedarbyshir

 NuvOx Pharma’s technology, which is developed as a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, was featured in the prominent journal of Frontiers of Neurology. In its March 2022 edition, the article “Systematic Review – Combining Neuroprotection with Reperfusion in Acute Ischemic Stroke” (by William Culp, et. al.), screened 1764 titles/abstracts of studies of neuroprotectants in stroke and selected the top 30 full reports from unique studies. The paper, “Dodecafluoropentane emulsion in acute ischemic stroke: a phase Ib/II randomized and controlled dose-escalation trial,” published in the Journal of Vascular Interventional Radiology was selected as one of ... Read more